Keyphrases
Adjusted Dose
10%
Adjusted Model
10%
Benign Meningioma
100%
Cancer Diagnosis
10%
Cancer Oncology
100%
Carboplatin
20%
Chemotherapy
10%
Chemotherapy Agents
10%
Childhood Cancer
100%
Childhood Cancer Survivors
30%
Cisplatin
10%
Cranial Radiotherapy
100%
Cranial Volume
100%
Cumulative Incidence
10%
Dose Effect
10%
Dose-response
10%
Dutch
100%
Excess Relative Risk
20%
Exposure Age
30%
Hazard Ratio
60%
Hazard Risk
30%
High Dose
10%
Joint Effect
10%
Meningioma
60%
Methotrexate
10%
Multivariable Cox Regression
10%
PALGA
10%
Partial Volume
10%
Pediatric
10%
Population-based
10%
Primary Cancer
10%
Radiation Dose
100%
Radiation Exposure
10%
Radiotherapy Dose
30%
Radiotherapy Volumes
10%
Risk Factors
10%
Risk Modeling
10%
Survivors
20%
Treatment Protocol
10%
Medicine and Dentistry
Awareness
10%
Cancer Diagnosis
10%
Carboplatin
20%
Chemotherapy Agent
10%
Childhood Cancer
100%
Cisplatin
10%
Cumulative Incidence
10%
Dose Response
20%
Drug Megadose
10%
Hazard Ratio
60%
Malignant Neoplasm
100%
Meningioma
100%
Methotrexate
10%
Oncology
100%
Pediatrics
10%
Primary Tumor
10%
Proportional Hazards Model
10%
Radiation Therapy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Carboplatin
22%
Chemotherapy
11%
Chemotherapy Agent
11%
Childhood Cancer
100%
Cisplatin
11%
Malignant Neoplasm
100%
Meningioma
100%
Methotrexate
11%
Primary Tumor
11%